Browse current and past press releases from The Michael J. Fox Foundation.
-
The Michael J. Fox Foundation Launches Initiative to Expedite Development of LRRK2-targeted Therapies and Biomarkers for Parkinson’s Disease
-
-
FDA Issues ‘Letter of Support’ Encouraging Use of Synuclein-based Biomarker, αSyn-SAA, in Clinical Trials in Parkinson’s and Related Diseases
-
Rowers Complete Record-breaking 2,800-mile Open Ocean Row to Benefit Michael J. Fox Foundation, Increase Fundraising Goal to $41 Million
-
Four Open-Ocean Rowers Embark On 2,800 Mile Cross-Pacific Journey for The Michael J. Fox Foundation and Inspire “Summer Challenge” with an Unprecedented 3:1 Donation Match
-
Michael J. Fox Foundation Funds Projects to Speed Development of Quantitative Biomarkers for Parkinson’s Disease
-
The Michael J. Fox Foundation Applauds Passage of National Plan to End Parkinson’s Act in Congress